Danielle Hammond

28PUBLICATIONS
124CO-AUTHORS
Haematological tumoursMolecular targetsRegenerative medicine (incl. stem cells)PharmacogenomicsMedical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (28)

|Jun 22, 2026
Investigational clinical trial agents versus conventional second salvage therapies in patients with relapsed/refractory acute myeloid leukemia.

|May 15, 2026
The First Reported Case of VEXAS Syndrome in Lebanon: Efficacy of Azacitidine as a Therapeutic Option-Case Report.

|Mar 28, 2026
Impact of allogeneic stem cell transplantation in patients with higher risk myelodysplastic syndromes.

Alexandre Bazinet, Alex Bataller, Kelly Chien

|Feb 27, 2026
PAXIS: A Randomized, Double-Blind, Placebo-Controlled, Dose-Finding Phase 2 Study (Part 1) Followed by an Open-Label Period (Part 2) to Assess the Efficacy and Safety of Pacritinib in Patients with VEXAS Syndrome.

David B Beck, Maël Heiblig, Sinisa Savic

|Feb 24, 2026
Overcoming menin inhibitor resistance in AML cells with combinations including BET proteins and a dual BRG1/BRM inhibitor.

Warren Fiskus, Christopher P Mill, Ghayas C Issa

|Jan 26, 2026
Incorporation of Genomic Determinants Improves Diagnostic Accuracy of Oligomonocytic Chronic Myelomonocytic Leukemia.

Guillermo Montalban-Bravo, Chong Wu, Juan Jose Rodriguez-Sevilla

Pageof 5

Frequent Collaborators

23 joint publications

Courtney DiNardo

19 joint publications

Tapan M Kadia

19 joint publications

Koji Sasaki

18 joint publications

Kelly Sharon Chien